Understanding the Benefits of SPRAVATO Spray

For millions of people struggling with depression, trying one treatment after another without relief can feel hopeless. A different approach, designed for this exact situation, may offer a new kind of hope when other options have fallen short.

This is the idea behind SPRAVATO®, an FDA-approved prescription nasal spray. It's not a first-step treatment; rather, it's used with an oral antidepressant for adults with treatment-resistant depression. This clinical term describes depression that hasn't improved enough after trying at least two other antidepressant medications---a scenario familiar to many who feel stuck.

Because the process is so different, from how it's taken to where it's administered, it's natural to have questions. This guide covers the potential benefits, what to expect during a treatment session, and the important safety information you need to have a meaningful conversation with your doctor about this unique medication.

What Is Treatment-Resistant Depression and Who Is SPRAVATO® For?

For many people living with depression, finding the right medication can be a frustrating journey. When you've put your hope into different treatments only to find they don't provide the relief you need, it can be deeply discouraging. This experience has a clinical name: treatment-resistant depression (TRD). It's not a personal failure or a sign of weakness; it is a recognized medical challenge where standard treatments haven't been effective enough.

A healthcare provider diagnoses TRD after determining that you have tried at least two different oral antidepressant medications for a long enough period, at an adequate dose, without seeing significant improvement. This diagnosis helps identify when a different kind of treatment may be necessary to find a path toward feeling better.

This specific situation is exactly who SPRAVATO® is intended for. It is not a first-choice medication. Instead, this treatment is a prescription nasal spray used along with a daily oral antidepressant for adults with TRD. If you feel you've run out of options, knowing about this specific indication is the first step in discussing with your doctor whether a new approach could be right for you.

How SPRAVATO® Works Differently: A New Path in Your Brain's Communication Network

Many common oral antidepressants work similarly, often by focusing on a brain chemical called serotonin. While these medications help many people, if they haven't worked for you, it can feel like you're just trying slightly different keys for the same stubborn lock. SPRAVATO® was designed to offer a completely different kind of key, working on a pathway that other antidepressants typically don't.

Instead of serotonin, the esketamine nasal spray works on glutamate, a different and more abundant chemical messenger in the brain. Think of your brain's communication system as a complex map of roads. Serotonin is like one major highway that many treatments try to repair. Glutamate, however, is like the vast network of local streets and intersections connecting everything. By targeting this broader system, SPRAVATO® is thought to help restore communication between brain cells, opening up a new route toward feeling better.

This fundamentally different approach is why this esketamine nasal spray may be effective for individuals who haven't found relief with other treatments. It isn't just a stronger version of a pill; it's a treatment that engages the brain in a new way. Because it works so differently, the process of receiving the treatment is also unique.

Your First SPRAVATO® Session: What to Expect Step-by-Step

Because SPRAVATO® works differently in the brain, the way you receive it is also different from a daily pill. The treatment is given at a certified clinic to ensure your comfort and safety from start to finish. Knowing what to expect during treatment sessions can help ease any uncertainty about trying a new approach.

A typical treatment day follows a simple, structured process. After you arrive, your healthcare provider will make sure you're ready and answer any questions. The core of your visit will look like this:

1. Check-In & Get Comfortable: You'll be shown to a private, relaxing space, often with a comfortable reclining chair.

2. Self-Administer the Nasal Spray: A healthcare professional will show you how to use the nasal spray device, which you will then administer yourself under their supervision.

3. Rest & Monitor: You will then relax for at least two hours while your provider monitors you.

One aspect that might surprise you is that you are the one who uses the nasal spray, keeping you in control of the process. The two-hour monitoring period that follows is a quiet time to rest. Many people bring headphones to listen to music or a podcast, or simply close their eyes. You will need to have a friend or family member drive you home afterward, as you shouldn't drive or operate machinery until the next day.

This entire process is designed with your safety as the top priority, and the two-hour observation is key to managing any temporary side effects that SPRAVATO® can cause right after treatment.

Understanding Side Effects: Why In-Clinic Monitoring Is a Key Safety Feature

That two-hour monitoring period exists specifically to manage the most common SPRAVATO® side effects, which occur shortly after treatment and are temporary. Many people feel very sleepy or dizzy, and some experience a short-term increase in blood pressure. Because these effects are well-known and expected, your healthcare team is right there to watch over you. They ensure you are safe and comfortable in a relaxing environment until the effects wear off and it is safe for you to head home.

Another possible side effect is a feeling called dissociation. This might feel like you are briefly disconnected from your thoughts, your feelings, or even your body. For some, the world around them might seem strange for a little while. While this can be an unfamiliar sensation, it is also temporary and typically resolves during the observation period. Knowing this can help you relax into the experience, and your provider is there to offer support.

This structured approach is not just a clinic's policy; it's part of a mandatory safety program required by the FDA. This program ensures that every certified clinic follows strict protocols for administering SPRAVATO® and monitoring patients. It's an essential layer of security, designed to make sure everyone receiving the treatment is cared for responsibly.

SPRAVATO® vs. Ketamine Infusions: Clarifying the Key Differences

If you've researched depression treatments online, you may have come across both SPRAVATO® and ketamine infusions. While they are related, they are not the same. SPRAVATO® contains esketamine, which is one part of the ketamine molecule. More importantly, SPRAVATO® is the only one of the two that is specifically FDA-approved for adults with treatment-resistant depression (TRD).

This distinction leads to several practical differences in how these treatments are provided:

• FDA Approval: SPRAVATO® is an FDA-approved medication for TRD. Intravenous (IV) ketamine is used "off-label" for depression, meaning it's being used for a purpose other than what it was officially approved for (anesthesia).

• Administration: The SPRAVATO® nasal spray is self-administered by the patient under a provider's supervision. In contrast, IV ketamine is delivered directly into a vein through a needle by a healthcare professional.

• Safety Program: Because it is FDA-approved, SPRAVATO® must be given under a strict safety program (REMS) that standardizes monitoring and patient care. Ketamine clinics are not required to follow this specific program and may have widely varying protocols.

Ultimately, these differences matter for your care. The FDA approval and required safety program for SPRAVATO® create a predictable and regulated treatment framework focused on ensuring patient safety. This standardized approach provides a consistent level of oversight for every person receiving the treatment.

How to Qualify for SPRAVATO® and Find a Certified Clinic

Because SPRAVATO® is specifically for treatment-resistant depression, the first step is always a detailed evaluation with your healthcare provider. This isn't a treatment you can simply request; it requires a professional medical diagnosis. During this conversation, your doctor will work with you to carefully review your symptoms and past experiences to confirm that your depression meets the clinical criteria.

A crucial part of that evaluation will be documenting your patient treatment history. To be eligible, your doctor must verify that you have already tried at least two different oral antidepressant medications for an adequate amount of time without achieving the desired relief. It's helpful to prepare for this discussion by recalling which medications you've taken, for how long, and how they affected you. This history is the key evidence needed before starting a SPRAVATO® treatment plan.

If you and your doctor decide to move forward, the treatment cannot be picked up at a regular pharmacy. Due to the required safety monitoring, SPRAVATO® is only administered in specially certified treatment clinics. The manufacturer provides an official locator tool on the SPRAVATO® website, which allows you to search for approved healthcare facilities in your area.

The Cost of SPRAVATO®: Navigating Insurance and Financial Support

The total cost of esketamine treatment involves two main parts: the cost of the SPRAVATO® nasal spray itself, and the separate fee for the clinic's services, which covers the time you are monitored by healthcare professionals. Because of this two-part structure, determining the final expense isn't as simple as looking up a typical prescription price, and your insurance plan plays a critical role.

For many, esketamine therapy is covered by insurance, but it typically requires prior authorization. This is a process where your doctor's office must submit information to your insurance provider to get approval before you start treatment. They will use your medical records to show why SPRAVATO® is medically necessary for you, which is why having a clear treatment history is so important.

Navigating this process can feel overwhelming, but you and your doctor's office don't have to do it alone. The manufacturer of SPRAVATO® offers a dedicated support program to help patients manage the financial aspect of care. This service can help investigate your insurance benefits, assist with the prior authorization process, and identify financial assistance programs you may be eligible for, allowing you to focus on your health journey.

Is SPRAVATO® an Option for You? Questions to Ask Your Doctor

SPRAVATO® is a different kind of depression treatment: a nasal spray for treatment-resistant depression that works on a new brain pathway, with a unique in-clinic process designed entirely around your safety. This knowledge can give you confidence for your next conversation about your care.

To help you start that dialogue, consider bringing these questions to your doctor's appointment:

• Based on my treatment history, do you think I have TRD?

• What are the potential benefits and risks for me specifically?

• What would the treatment schedule look like?

• Can your office help me with the insurance pre-authorization process?

Discussing your options for treatment-resistant depression is a hopeful, proactive step. The path forward is a decision made with your doctor, who can also guide you in finding a certified esketamine clinic if it's a good fit. You are now equipped to begin that important conversation.

Q&A

Question: Who is SPRAVATO® for, and how is treatment-resistant depression (TRD) diagnosed?

Short answer: SPRAVATO® is for adults with treatment-resistant depression—meaning your depression hasn’t improved enough after trying at least two different oral antidepressants at adequate doses and durations. It isn’t a first-choice medication and is used together with a daily oral antidepressant. A healthcare provider must review your symptoms and documented treatment history to confirm TRD before considering SPRAVATO®.

Question: How does SPRAVATO® work differently from typical antidepressants?

Short answer: Most oral antidepressants target serotonin, but SPRAVATO® (esketamine) acts on the glutamate system, a broader brain communication network. By engaging this different pathway, it may help restore connections between brain cells in people who haven’t found relief with other treatments. It isn’t just a stronger pill—it’s a nasal spray that works through a distinct mechanism and is administered in a clinical setting.

Question: What should I expect during a SPRAVATO® treatment session?

Short answer: Sessions take place at a certified clinic. You’ll check in, get comfortable in a private space, and self-administer the nasal spray under a provider’s supervision. You’ll then rest while being monitored for at least two hours. Many people bring headphones or rest quietly. You’ll need someone to drive you home, and you shouldn’t drive or operate machinery until the next day.

Question: Why is in-clinic monitoring required, and what side effects might occur?

Short answer: Monitoring helps manage common, temporary side effects that can occur shortly after dosing — such as sleepiness, dizziness, a short-term rise in blood pressure, or dissociation (feeling briefly disconnected from thoughts or surroundings). These effects typically resolve during observation. The monitoring and administration are part of an FDA-required safety program (REMS) that standardizes patient care.

Question: How does SPRAVATO® differ from ketamine infusions, and how is it accessed and paid for?

Short answer: SPRAVATO® (esketamine) is FDA-approved specifically for adults with TRD and must be given under a strict REMS safety program. Ketamine infusions use IV ketamine off-label for depression and may follow varying clinic protocols. SPRAVATO® can only be administered at certified clinics (not a regular pharmacy); you can find one via the manufacturer’s locator. Costs include the medication and separate clinic monitoring fees. Many insurance plans cover treatment but typically require prior authorization using your documented treatment history. The manufacturer offers support to check benefits, assist with authorization, and identify financial assistance options.